Over the last decade, considerable attention has been paid to the origin of the myofibroblast, the mesenchymal cell type most responsible for the excessive matrix production and deposition in tissue and vessel walls found in fibrotic disorders and fibroproliferative vasculopathies, respectively (1). In this context, the myofibroblast has increasingly been regarded as a crucial effector cell in the pathogenesis of systemic sclerosis (SSc; scleroderma), a multifaceted connective tissue disorder characterized by both skin and internal organ fibrosis and a severe proliferative vasculopathy affecting small and medium-sized arterioles and capillaries (2–4). In SSc, organ dysfunction and failure are ultimately caused by overproduction and accumulation, in affected tissue, of extracellular matrix components, such as types I and III collagen and fibronectin (2,3). Moreover, the concomitant fibroproliferative vasculopathy, characterized by subendothelial intimal fibrosis, may lead to severe vascular complications, including digital ulceration and gangrene, pulmonary arterial hypertension, and scleroderma renal crisis. These events heavily jeopardize patients’ quality of life and are associated with very poor prognosis (4). Despite numerous recent advances in the understanding of the molecular regulation of genes encoding collagens and other extracellular matrix proteins, the complex mechanisms responsible for the heterogeneous pathogenesis of SSc remain unknown (5). As a consequence, no targeted and disease-modifying therapies are available to control, arrest, or reverse disease progression and fibrosis (6). It is well known that fibroblasts are dysregulated, that they transform into myofibroblasts, and that they produce an excessive amount of collagen and other extracellular matrix components in SSc (7). For this reason, the pivotal goal of a research agenda today is the identification of the origin of tissue and subendothelial myofibroblasts, together with the intracellular transduction pathways involved in the transcriptional activation of the genes required for the recruitment and transdifferentiation of myofibroblasts from their putative cellular precursors.